Esperion Therapeutics Inc... (ESPR)
NASDAQ: ESPR
· Real-Time Price · USD
2.15
0.08 (3.86%)
At close: Aug 15, 2025, 9:56 AM
Esperion Therapeutics Income Statement
Financials in USD. Fiscal
year is
January - December.
| Fiscal Year | Q2 2025 | Q1 2025 | Q4 2024 | Q3 2024 | Q2 2024 | Q1 2024 | Q4 2023 | Q3 2023 | Q2 2023 | Q1 2023 | Q4 2022 | Q3 2022 | Q2 2022 | Q1 2022 | Q4 2021 | Q3 2021 | Q2 2021 | Q1 2021 |
| Period Ending | Jun 30, 2025 | Mar 31, 2025 | Dec 31, 2024 | Sep 30, 2024 | Jun 30, 2024 | Mar 31, 2024 | Dec 31, 2023 | Sep 30, 2023 | Jun 30, 2023 | Mar 31, 2023 | Dec 31, 2022 | Sep 30, 2022 | Jun 30, 2022 | Mar 31, 2022 | Dec 31, 2021 | Sep 30, 2021 | Jun 30, 2021 | Mar 31, 2021 |
Revenue | 268.13M | 259.57M | 332.31M | 295.45M | 277.79M | 229.74M | 116.33M | 102.9M | 87.91M | 80.97M | 75.47M | 72.06M | 67.49M | 89.31M | 78.45M | 72.68M | 62.11M | 233.69M |
Cost of Revenue | 95.06M | 90.06M | 68.6M | 54.42M | 50.51M | 41.69M | 43.27M | 35.98M | 29.1M | 31.49M | 26.97M | 27.88M | 26.93M | 19.56M | 14.22M | 10.83M | 5.55M | 4.14M |
Gross Profit | 173.06M | 169.51M | 263.71M | 241.03M | 227.28M | 188.05M | 73.07M | 66.93M | 58.81M | 49.47M | 48.51M | 44.18M | 40.55M | 69.75M | 64.23M | 61.85M | 56.56M | 229.54M |
Operating Income | -27.51M | -39.96M | 54.4M | 16.45M | 4.95M | -34.69M | -155.56M | -155.71M | -169.8M | -185.12M | -179.5M | -192.62M | -206.74M | -186.9M | -226.73M | -266.67M | -291.48M | -129.77M |
Interest Income | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a |
Pretax Income | -96.09M | -153.22M | -51.74M | -86.77M | -98.5M | -86.51M | -209.25M | -208.39M | -222.26M | -238.65M | -233.66M | -243.29M | -257.56M | -234.9M | -269.11M | -308.46M | -324.52M | -156.24M |
Net Income | -96.09M | -153.22M | -51.74M | -86.77M | -98.5M | -86.51M | -236.75M | -248.87M | -276.23M | -306.56M | -287.82M | -284.48M | -285.25M | -248.65M | -269.11M | -308.46M | -324.52M | -156.24M |
Selling & General & Admin | 159.41M | 164.08M | 163.07M | 171.57M | 164.84M | 154.61M | 142.52M | 121.24M | 112.95M | 108.6M | 109.08M | 123.28M | 137.59M | 154.3M | 184.99M | 208.2M | 217.76M | 219.13M |
Research & Development | 41.17M | 45.39M | 46.24M | 53M | 57.49M | 68.13M | 86.11M | 101.4M | 115.66M | 125.99M | 118.93M | 113.51M | 109.7M | 102.34M | 105.97M | 120.32M | 130.28M | 140.19M |
Other Expenses | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | 318K | 638K | 638K | 651K | 342K | 36K | 60K | 89K | 161K |
Operating Expenses | 200.57M | 209.47M | 209.31M | 224.57M | 222.33M | 222.74M | 228.63M | 222.64M | 228.61M | 234.59M | 228.01M | 236.79M | 247.29M | 256.64M | 290.96M | 328.52M | 348.04M | 359.31M |
Interest Expense | 71.42M | 64.66M | 59.25M | 57.89M | 57.8M | 58.61M | 58.98M | 58.25M | 57.41M | 57.13M | 56.81M | 55.91M | 55.41M | 52.29M | 46.35M | 41.85M | 33.13M | 26.62M |
Selling & Marketing Expenses | 25.5M | 25.5M | 25.5M | n/a | n/a | n/a | n/a | 11.3M | 11.3M | 11.3M | 11.3M | 13.7M | 13.7M | 13.7M | 13.7M | 20M | 20M | 20M |
Cost & Expenses | 295.64M | 299.54M | 277.91M | 279M | 272.84M | 264.43M | 271.9M | 258.61M | 257.71M | 266.08M | 254.98M | 264.67M | 274.23M | 276.2M | 305.18M | 339.36M | 353.58M | 363.46M |
Income Tax Expense | n/a | n/a | -41K | -41K | -67K | -118K | 27.42M | 40.4M | 53.92M | 67.92M | 54.16M | 41.18M | 27.69M | 13.74M | n/a | n/a | n/a | n/a |
Shares Outstanding (Basic) | 196.84M | 196.13M | 195.57M | 194.93M | 188.79M | 169.26M | 112.4M | 111.87M | 109.24M | 78.44M | 73.49M | 67.81M | 63.23M | 60.95M | 36.85M | 26.46M | 26.23M | 25.99M |
Shares Outstanding (Diluted) | 196.84M | 196.13M | 195.57M | 194.93M | 188.79M | 189.64M | 112.4M | 111.87M | 109.24M | 78.44M | 73.49M | 67.81M | 63.23M | 60.95M | 36.85M | 26.46M | 26.23M | 25.99M |
EPS (Basic) | -0.49 | -0.8 | -0.23 | -0.62 | -0.84 | -0.97 | -2.47 | -2.9 | -3.54 | -4.35 | -4.37 | -5.21 | -6.82 | -7.22 | -9.56 | -11.68 | -12.13 | -5.96 |
EPS (Diluted) | -0.49 | -0.8 | -0.25 | -0.64 | -0.86 | -0.99 | -2.47 | -2.9 | -3.54 | -4.35 | -4.37 | -5.21 | -6.82 | -7.22 | -9.56 | -11.68 | -12.13 | -6.14 |
EBITDA | -24.59M | -88.47M | 7.57M | -28.84M | -40.66M | -27.81M | -150.11M | -149.89M | -164.52M | -181.08M | -176.35M | -186.82M | -201.54M | -182M | -222.14M | -265.99M | -290.76M | -129.02M |
EBIT | -24.67M | -88.56M | 7.51M | -28.89M | -40.7M | -27.89M | -150.27M | -150.14M | -164.85M | -181.51M | -176.85M | -187.38M | -202.15M | -182.61M | -222.75M | -266.61M | -291.39M | -129.61M |
Depreciation & Amortization | 53K | 89K | 104K | 83K | 83K | 124K | 164K | 250K | 329K | 428K | 500K | 561K | 609K | 612K | 612K | 619K | 629K | 594K |